Aldigier J C, Plouin P F, Alexandre J M, Corvol P, Menard J
J Cardiovasc Pharmacol. 1981 Nov-Dec;3(6):1229-35. doi: 10.1097/00005344-198111000-00009.
In a double-blind randomized study, the dose response to captopril was studied in 12 severely hypertensive patients whose blood pressure had been previously controlled by this converting enzyme inhibitor, either in association with a diuretic (seven patients), or with a diuretic and a beta-blocker (five patients). All patients received in random sequence 32.5, 75, and 150 mg/day of captopril in three divided doses. Significant correlations were revealed between the dose administered and the levels of arterial blood pressure, plasma renin, plasma aldosterone and plasma potassium. Under the conditions of this study, dose-response curves were obtained for concentrations of captopril between 0.5 and 4 mg/day/kg body weight.
在一项双盲随机研究中,对12名重度高血压患者进行了卡托普利的剂量反应研究。这些患者之前的血压一直通过这种转换酶抑制剂控制,其中7名患者联合使用了利尿剂,5名患者联合使用了利尿剂和β受体阻滞剂。所有患者随机依次接受每日32.5、75和150毫克卡托普利,分三次服用。研究发现给药剂量与动脉血压、血浆肾素、血浆醛固酮和血浆钾水平之间存在显著相关性。在本研究条件下,获得了卡托普利浓度在0.5至4毫克/天/千克体重之间的剂量反应曲线。